Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-09-21

FDA Approved: DRONABINOL — Supplemental Application (Wellhouse Pharma, LLC)

View source ↗

Summary

FDA approved a supplemental application for dronabinol submitted by Wellhouse Pharma, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dronabinol (dronabinol)

Snippet

SUPPL AP for DRONABINOL (DRONABINOL)